Natixis Portfolio holdings
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$542M |
| 2 |
Apple
AAPL
|
+$491M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$419M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$304M |
| 5 |
Amazon
AMZN
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$631M |
| 2 |
Prologis
PLD
|
+$102M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$100M |
| 4 |
Cigna
CI
|
+$81.6M |
| 5 |
Procter & Gamble
PG
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.25% |
| 2 | Consumer Discretionary | 9.63% |
| 3 | Financials | 8.45% |
| 4 | Healthcare | 7.42% |
| 5 | Communication Services | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Pacira BioSciences
PCRX
$1.02B
| $95K | ﹤0.01% |
+3,250
| New | +$99.8K |
|
777
PIMCO Dynamic Income Fund
PDI
$7.4B
| $94.6K | ﹤0.01% |
4,902
-806
| -14% | -$15.3K |
|
778
Ameren
AEE
$31.5B
| $91.4K | ﹤0.01% |
+1,236
| New | +$87.9K |
|
779
C.H. Robinson
CHRW
$22B
| $90.2K | ﹤0.01% |
1,185
-12,454
| -91% | -$974K |
|
780
Robert Half
RHI
$3.61B
| $90.2K | ﹤0.01% |
+1,138
| New | +$91.7K |
|
781
West Fraser Timber
WFG
$5.18B
| $90.1K | ﹤0.01% |
1,043
-9
| -0.9% | -$736 |
|
782
Columbia Sportswear
COLM
$3.19B
| $89.3K | ﹤0.01% |
1,100
-13,200
| -92% | -$1.05M |
|
783
Ionis Pharmaceuticals
IONS
$9.35B
| $85K | ﹤0.01% |
1,961
-917
| -32% | -$43.7K |
|
|
LICY
784
DELISTED
Li-Cycle Holdings Corp.
LICY
| $83.5K | ﹤0.01% |
10,130
-386
| -4% | -$1.74K |
|
785
Hamilton Lane
HLNE
$3.63B
| $83.4K | ﹤0.01% |
740
-274
| -27% | -$30.9K |
|
786
N-able
NABL
$769M
| $80.8K | ﹤0.01% |
6,184
-6,372
| -51% | -$84.3K |
|
787
Kymera Therapeutics
KYMR
$9.1B
| $79.6K | ﹤0.01% |
1,979
-1,992
| -50% | -$71.3K |
|
788
CNX Resources
CNX
$4.85B
| $78.8K | ﹤0.01% |
+3,324
| New | +$69K |
|
789
Legend Biotech
LEGN
$4.3B
| $78.8K | ﹤0.01% |
1,404
-618
| -31% | -$37.3K |
|
|
APLS
790
DELISTED
Apellis Pharmaceuticals
APLS
| $78.7K | ﹤0.01% |
1,339
-90,719
| -99% | -$5.78M |
|
791
SS&C Technologies
SSNC
$17.8B
| $77.2K | ﹤0.01% |
+1,200
| New | +$74.5K |
|
792
Sarepta Therapeutics
SRPT
$1.66B
| $77K | ﹤0.01% |
+595
| New | +$72.9K |
|
|
HEES
793
DELISTED
H&E Equipment Services
HEES
| $76.4K | ﹤0.01% |
1,190
-11
| -0.9% | -$603 |
|
794
BioNTech
BNTX
$22.6B
| $73.2K | ﹤0.01% |
793
-422
| -35% | -$40.5K |
|
|
BPMC
795
DELISTED
Blueprint Medicines
BPMC
| $72.9K | ﹤0.01% |
+768
| New | +$65.9K |
|
796
Five Below
FIVE
$11.2B
| $72.6K | ﹤0.01% |
+400
| New | +$77.1K |
|
797
Greystone Housing Impact Investors LP
GHI
$121M
| $71.2K | ﹤0.01% |
4,372
| – | – |
|
798
Encompass Health
EHC
$11.2B
| $70.6K | ﹤0.01% |
855
+530
| +163% | +$38.8K |
|
799
Nurix Therapeutics
NRIX
$2.43B
| $70.3K | ﹤0.01% |
4,783
-689
| -13% | -$7.41K |
|
800
Prestige Consumer Healthcare
PBH
$2.35B
| $67K | ﹤0.01% |
923
+722
| +359% | +$48.3K |
|
Similar funds
Natixis's Q1 2024 Portfolio in Review
As of Q1 2024, Natixis held 1,285 positions worth $19.2B, up 40% from $13.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Natixis deployed $3.46B of net new capital in Q1 2024, opening 260 new positions and adding to 345 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 2,100,100 shares worth $442M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $631M trimmed.
- Natixis's largest Q1 2024 buy was iShares Russell 2000 ETF: 2,100,100 shares worth $442M.
- Natixis added most to Microsoft in Q1 2024, an estimated $542M increase.
- Natixis's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $631M.
- Natixis fully exited Splunk Inc in Q1 2024, selling an estimated $68.7M.
- Natixis's ten largest holdings make up 39% of its $19.2B portfolio in Q1 2024.
- Natixis opened 260 new positions and closed 287 in Q1 2024.
- Natixis's portfolio value rose 40% quarter-over-quarter to $19.2B.
Based on Natixis's 13F filing for Q1 2024, filed 13 May 2024.